When it comes to investing in the biotech and health-tech startups, it can be hard to find a company that can turn an idea into a reality.
For one, developing new treatments is no small feat. And there is often a lot of interest concentrated on certain “buzzy” areas like immunotherapy or machine learning.
GV, formerly Google Ventures, has invested in a number of life sciences startups, including 23andMe, Foundation Medicine, and Flatiron Health.
